15 completed. 15 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 15 | Completed 15 |
| Phase 2 | 2 | Completed 2 |
Follow Chronic Renal Failure: new trials by email Literature Review of Chronic Renal Failure trials Research Report on Chronic Renal Failure
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Steroid Impregnated Tape in the Treatment of Over-granulating Peritoneal Dialysis Exit Sites Haelan tape (steroid impregnated tape), Silver Nitrate - Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis | Phase 3 | Completed | University Hospital Birmingham NHS Foundation Trust | 32 | 2013-12-01 | 2017-11-06 |
| Use Of Fragmin In Hemodialysis Fragmin - Chronic Renal Failure | Phase 3 | Completed | Pfizer | 152 | 2013-10-01 | 2017-03-10 |
| Effects of Dexmedetomidine Premedication on Geriatric Patients With Chronic Renal Failure Undergoing Hip Surgery dexmedetomidine infusion for premedication, Midazolam, saline infusion - Chronic Renal Failure, Hip Fracture | Phase 3 | Completed | Baskent University | 60 | 2012-12-01 | 2015-01-27 |
| A Phase 3 Study Comparing the Effects of Intravenous Epoetin Hospira and Epoetin Alfa [Epogen] (Amgen) in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With Epoetin Epoetin Hospira, Epogen (Amgen) - Chronic Kidney Disease, Chronic Renal Failure | Phase 3 | Completed | Pfizer | 612 | 2012-01-31 | 2018-09-10 |
| A Phase 3 Study Comparing the Effects of Subcutaneous Epoetin Hospira and Epoetin Alfa [Epogen] (Amgen) in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With Epoetin Epoetin Hospira, Epogen Amgen - Chronic Renal Failure, Chronic Kidney Disease | Phase 3 | Completed | Pfizer | 320 | 2012-01-17 | 2018-08-09 |
| FGF23 Reduction : Efficacy of a New Phosphate Binder in CHronic Kidney Disease Placebo, Sevelamer carbonate - Chronic Renal Failure | Phase 3 | Completed | Centre Hospitalier Universitaire, Amiens | 98 | 2010-10-01 | 2025-09-19 |
| Prasugrel Versus High Dose Clopidogrel in Clopidogrel Resistant Patients Undergoing Chronic Hemodialysis Prasugrel, Clopidogrel - Hemodialysis, Chronic Renal Failure | Phase 3 | Completed | University of Patras | 70 | 2010-05-01 | 2010-11-16 |
| TRK-100STP Clinical Study - Chronic Renal Failure (Primary Glomerular Disease/Nephrosclerosis) TRK-100STP high dose, TRK-100STP low dose, Placebo - Chronic Renal Failure, Glomerular Disease | Phase 2 / Phase 3 | Completed | Toray Industries, Inc | 892 | 2010-03-01 | 2015-02-04 |
| Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients Cinacalcet, Placebo - Chronic Allograft Nephropathy, Chronic Kidney Disease | Phase 3 | Completed | Amgen | 114 | 2009-12-03 | 2018-10-17 |
| Safety and Efficacy of Peginesatide for the Treatment of Anemia in Participants With Chronic Renal Failure Not on Dialysis peginesatide, Darbepoetin alfa - Chronic Renal Failure, Chronic Kidney Disease | Phase 3 | Completed | Affymax | 493 | 2007-11-01 | 2013-02-12 |
| Safety & Efficacy of Peginesatide for Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease on Hemodialysis peginesatide, Epoetin alfa or Epoetin beta - Chronic Renal Failure, Chronic Kidney Disease | Phase 3 | Completed | Affymax | 823 | 2007-10-01 | 2013-03-08 |
| Safety & Efficacy of Peginesatide for the Treatment of Anemia in Participants With Chronic Renal Failure Not on Dialysis peginesatide, Darbepoetin alfa - Chronic Renal Failure, Chronic Kidney Disease | Phase 3 | Completed | Affymax | 490 | 2007-10-01 | 2013-02-12 |
| Safety & Efficacy of Peginesatide for Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease on Hemodialysis peginesatide, Epoetin Alfa - Chronic Renal Failure, Chronic Kidney Disease | Phase 3 | Completed | Affymax | 803 | 2007-09-01 | 2013-02-12 |
| Pharmacodynamics and Non-Clinical Inferiority of Heparin Sodium (Cristália) Compared With the Product Liquemine (Roche) in Chronic Renal Failure Heparin sodic - Cristália, heparin - Liquemine (Roche) - Chronic Renal Failure | Phase 2 / Phase 3 | Completed | Azidus Brasil | 62 | 2007-09-01 | 2009-01-26 |
| Effect of Strict Blood Pressure Control and ACE-Inhibition on Progression of Chronic Renal Failure in Pediatric Patients ACE Inhibition, Intensified Blood Pressure Control, Add-on Angiotensin Receptor Blockade - Children, Chronic Renal Failure | Phase 3 | Completed | Heidelberg University | 400 | 1998-01-01 | 2010-01-12 |
Kidney Failure, Chronic (15) · Renal Insufficiency, Chronic (8) · Anemia (4) · Renal Insufficiency (2) · Cardiovascular Diseases (1) · Disease Progression (1) · Hip Fractures (1) · Hypercalcemia (1) · Hyperparathyroidism (1) · Hypertension (1) · Hypertrophy, Left Ventricular (1) · Hypophosphatemia (1) · Kidney Diseases (1) · Nephrosclerosis (1)
Chronic Disease (15) · Disease Attributes (15) · Female Urogenital Diseases (15) · Female Urogenital Diseases and Pregnancy Complications (15) · Male Urogenital Diseases (15) · Pathologic Processes (15) · Pathological Conditions, Signs and Symptoms (15) · Urogenital Diseases (15) · Urologic Diseases (15) · Kidney Diseases (14) · Renal Insufficiency (13) · Renal Insufficiency, Chronic (7) · Hematologic Diseases (4) · Hemic and Lymphatic Diseases (4) · Calcium Metabolism Disorders (1)
Epoetin Alfa (4) · hematide (4) · peginesatide (4) · Darbepoetin alfa (2) · Anesthesia, Spinal (1) · Cinacalcet (1) · Clopidogrel (1) · Dalteparin (1) · Dexmedetomidine (1) · Midazolam (1) · Prasugrel Hydrochloride (1) · Premedication (1) · Ramipril (1) · Sevelamer (1) · Silver Nitrate (1)
Affymax (4) · Pfizer (3) · Amgen (1) · Azidus Brasil (1) · Baskent University (1) · Centre Hospitalier Universitaire, Amiens (1) · Heidelberg University (1) · Toray Industries, Inc (1) · University Hospital Birmingham NHS Foundation Trust (1) · University of Patras (1)
United States (7) · France (4) · Germany (4) · Italy (4) · Poland (4) · Puerto Rico (3) · United Kingdom (3) · Bulgaria (2) · Canada (2) · Czechia (2) · Hungary (2) · Romania (2) · Spain (2) · Switzerland (2) · Turkey (Türkiye) (2)
Vice President, Clinical Development (4) · Anis Aribogan, Prof., MD (1) · Franz Schaefer, MD (1) · Gabriel Choukroun, Ph D, M D (1) · Lukas Foggensteiner, BM FRCP PhD (1) · Otto Mehls, MD (1)
PMID 23343061, PMID 23343062, PMID 32734207, PMID 35224730, PMID 36791280, PMID 14630977, PMID 14744931, PMID 15253732, PMID 15647341, PMID 15772249, PMID 16093916, PMID 25233856, PMID 26323728, PMID 29074818, PMID 30542622, PMID 37119829, PMID 40576086